IKT
Inhibikase Therapeutics Inc
2.10$
-1.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -5,159.2% | -344,243,100.0% | – | – | – | -20,345.5% | – | – | – | – | – | – | – | |
| 8.3% | 656,800.0% | – | – | – | 25.0% | – | – | – | – | – | – | – | |
| 163.1% | 12,224,900.0% | – | – | – | 30,100.0% | – | – | – | – | – | – | – | |
| 422.9% | 59,243,600.0% | – | – | – | -4,293.3% | – | – | – | – | – | – | – | |
| 251.6% | 1,423,800.0% | – | – | – | 0.0% | – | – | – | – | – | – | – | |
| 21,442.0% | -211,559,500.0% | – | – | – | -147,528.8% | – | – | – | – | – | – | – | |
| – | 3,598,600.0% | – | – | – | – | – | – | – | – | – | – | – | |
| 0.1% | -13,810,400.0% | – | – | – | 379,403.4% | – | – | – | – | – | – | – | |
| 16,283.0% | -569,613,000.0% | – | – | – | 211,529.1% | – | – | – | – | – | – | – | |
| -5,159.2% | -344,243,100.0% | – | – | – | -20,345.5% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.